Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.

A ProPublica report published earlier this month indicates that an increasing number of parents are choosing to skip the ...

Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...

The porous material, derived from shellfish, optimizes absorption while activating a previously overlooked blood-clotting mechanism, stemming bleeding within minutes. More than 11 million people in ...

Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...

Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, ...

Patients with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, live an average of only three years after ...

Nucleated red blood cells (NRBCs) are immature blood cells that shouldn’t appear in adult blood. The optimal NRBC count is 0, and even very low counts may prompt further testing. If NRBCs are present ...